Luis Marti-Bonmati is a Spanish professor and researcher. He is the director of the Clinical Area of Medical Imaging Department at , and Head of Radiology Department at QuironSalud Hospital, Valencia, Spain. Marti-Bonmati is the founder of QUIBIM S.L., and is the Director of its Scientific Advisory Board. He is a member of the . He is also the director of the Biomedical Imaging Research Group (GIBI230) at La Fe Health Research Institute. The group is now included in the Imaging La Fe node at Distributed Network for Biomedical Imaging (ReDIB) Unique Scientific and Technical Infrastructures (ICTS), Valencia, Spain.
He did his undergraduate medical training at the University of Valencia. He completed his postgraduate training as a resident in radiology. He obtained his doctoral thesis (Ph.D.) from the University of Valencia in 1990 with a thesis on magnetic resonance (MR) imaging in liver tumors.
He joined the radiology department at the first university hospital with an MR system in Spain in 1987. He became the section chief in Magnetic Resonance imaging in this Radiology department (1995) and became professor of radiology at the University of Valencia (2011).
Marti-Bonmati was appointed as President of the Sociedad Española de Diagnóstico por Imagen del Abdomen (SEDIA) in 2000 for seven years. He also served as the President of the European Society of Magnetic Resonance in Medicine and Biology from 2002 to 2004. For two years starting from 2008, he was appointed as the President of the Sociedad Española de RadiologÃÂa (SERAM). From 2013 to 2015, he served as the President of the European Society of Gastrointestinal and Abdominal Radiology.
He is also a part of the executive council and has served as director of the Research Committee of the European Society of Radiology (ESR, 2010âÂÂ2013). Marti-Bonmati also serves as the director of Imaging La Fe node at Distributed Network for Biomedical Imaging (ReDIB) Unique Scientific and Technical Infrastructures (ICTS), Valencia, Spain.
Since January 2023, he has been the Scientific Director of the EUropean Federation for CAncer IMages project (EUCAIM) (proposal nú101100633). EUCAIM is a pan-European digital federated infrastructure of FAIR, de-identified cancer medical images coming from Real-World data. The infrastructure is an experimentation platform to facilitate the development and benchmarking of AI-based cancer management tools towards precision medicine in cancer diagnosis and treatment.
In 2023 he set up Fundación IMAGING, a non-profit foundation related to imaging.
Marti-Bonmati's research interests include liver MR and CT, abdominal and pelvic MRI, contrast agents, image processing, and imaging biomarkers. He also worked in the evaluation ofÃÂ liver segmentation, the quantification of emphysema and pulmonary vascularization, joint cartilage thickness, schizophrenia, and the microstructure, rigidity, and fragility of the trabecular bone.
His group is involved in providing medical imaging AI solutions as part of cancer management. They are working on image repositories, data harmonization, radiomics, deep features, interoperability, digital twins, in silico emulated trials, open source approaches and image preparation.
MartÃÂ-BonmatÃÂ has also published several books.